Related Experiment Video

Updated: Feb 1, 2026

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
07:39

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions

Published on: November 17, 2021

4.0K

Cofactors of Pediatric Tinnitus: A Look at the Whole Picture

Jessica Levi1,2, Krystyne Basa1,2, Kevin Wong1,2

  • 11 Boston Medical Center, Boston, MA USA.

Clinical Pediatrics
|December 4, 2018
PubMed

Insights

This study on pediatric tinnitus found rhinosinusitis may be a predictor, unlike otitis media. Further research is needed on imaging and psychiatric links in young children with tinnitus.

Area of Science:

  • Pediatric Otolaryngology
  • Audiology
  • Child Psychiatry

Background:

  • Pediatric tinnitus is complex, with varied potential contributing factors.
  • Understanding cofactors is crucial for accurate diagnosis and management in children.

Purpose of the Study:

  • To identify predictors and cofactors associated with pediatric tinnitus.
  • To investigate the prevalence of certain conditions in children with tinnitus compared to the general population.

Main Methods:

  • Retrospective chart review of 248 children (aged 1-19) with tinnitus.
  • Analysis of demographics, symptoms, medical history, imaging, and lab results.
  • Comparison with general population data.

Main Results:

  • 87% of children had normal hearing.
  • Lower incidence of otitis media and Eustachian tube dysfunction observed.
  • Higher incidence of rhinosinusitis noted; prevalence of dizziness, asthma, and hearing loss similar to the general population.

Conclusions:

  • Rhinosinusitis may be a significant cofactor in pediatric tinnitus.
  • Gaps exist in understanding the role of imaging and psychiatric diagnoses in younger children.
  • Improved patient reporting and objective testing are needed for pediatric tinnitus detection.

Keywords:
comorbiditieshearing losspediatricprimary caretinnitus

More Related Videos

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure15:18

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

18.7K
Guidelines for Elective Pediatric Fiberoptic Intubation11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.5K

Related Concept Videos

Cofactors and Coenzymes01:27

Cofactors and Coenzymes

Enzymes require additional components for proper function. There are two such classes of molecules: cofactors and coenzymes. Cofactors are metallic ions and coenzymes are non-protein organic molecules. Both of these types of helper molecule can be tightly bound to the enzyme or bound only when the substrate binds.
87.6K
Cofactors and Coenzymes01:24

Cofactors and Coenzymes

Enzymes are proteins made of amino acids. The functional group of each constituent amino acid catalyzes a wide variety of chemical reactions via ionic interactions or acid-base reactions. However, amino acids cannot catalyze oxidation-reduction and group transfer reactions and need to be aided by non-protein components called cofactors. Cofactors are also referred to as the chemical teeth of an enzyme.
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...
12.8K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
261
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
307
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
227
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
298